Article Text

Download PDFPDF
EP1195 Circulating microRNAs in differential diagnosis of vulvar intraepithelial lesions and vulvar squamous cell carcinoma
  1. K Zalewski1,2,3,
  2. M Szczyrek1,
  3. A Kowalik4,
  4. A Długosz5,
  5. M Misiek2,
  6. M Bidziński6,
  7. K Goryca7 and
  8. M Kowalewska1,5
  1. 1Department of Molecular and Translational Oncology, Maria Sklodowska-Curie Institute - Oncology Center, Warsaw
  2. 2Department of Gynecologic Oncology, Holycross Cancer Center, Kielce
  3. 3Chair and Department of Obstetrics, Gynecology and Oncology, 2nd Faculty of Medicine, Warsaw Medical University, Warsaw
  4. 4Department of Molecular Diagnostics, Holycross Cancer Center, Kielce
  5. 5Department of Immunology, Biochemistry and Nutrition, Medical University of Warsaw
  6. 6Gynecologic Oncology Department
  7. 7Department of Genetics, Maria Sklodowska-Curie Institute - Oncology Center, Warsaw, Poland


Introduction/Background Vulvar squamous cell carcinoma (VSCC) develops from vulvar squamous intraepithelial lesions (VIN). VIN is subdivided into two types, high grade-squamous intraepithelial lesion (HSIL) and differentiated vulvar intraepithelial neoplasia (dVIN), which differ by pathogenesis and clinical course. No molecular markers allowing precise and non-invasive diagnosis and/or differentiation of malignant and premalignant lesions of the vulva have been developed to date. This study aimed to identify circulating microRNAs as markers for differential diagnostics of VIN and VSCC.

Methodology Expression levels of 20 microRNAs were analyzed by quantitative RT-PCR in the plasma samples of 19 patients with VIN (HSIL and dVIN), 41 patients with VSCC and 15 healthy female donors (control group). The microRNA levels were normalized to hsa-miR-93-5p and hsa-miR-425-5p.

Results The levels of three microRNA molecules, namely miR-7-5p, miR-630 and miR-23b-3p were found to differentiate plasma samples of obtained from healthy donors, VIN and VSCC patients. The levels of miR-7-5p and miR-630 were decreased in blood of patients with VSCC as compared to VIN and controls. In contrary, the levels of miR-23b-3p were decreased in the blood of VSCC patients as compared to VIN and healthy donor samples. These differences were statistically significant.

Conclusion Our data reveal high diagnostic potential of the assessment of levels of circulating miR-7-5p, miR-23b-3p and miR-630 in VIN and VSCC patients.

Disclosure Nothing to disclose

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.